Alliance Pharma (LON:APH) Downgraded by Berenberg Bank to “Hold”

Berenberg Bank downgraded shares of Alliance Pharma (LON:APH) to a hold rating in a research note issued to investors on Wednesday morning,Digital Look reports. They currently have GBX 6,250 ($77.81) target price on the stock, down from their previous target price of GBX 7,000 ($87.15).

Alliance Pharma Stock Performance

Shares of LON APH traded up GBX 0.10 ($0.00) during midday trading on Wednesday, reaching GBX 61.20 ($0.76). The company’s stock had a trading volume of 4,345,835 shares, compared to its average volume of 8,341,226. Alliance Pharma has a 12-month low of GBX 24.55 ($0.31) and a 12-month high of GBX 61.60 ($0.77). The firm has a 50 day moving average price of GBX 50.26 and a 200-day moving average price of GBX 44.25. The stock has a market capitalization of £330.83 million, a P/E ratio of -1,020.00, a PEG ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.